SLC16A3 and neoplasm: During anti-PD-1 treatment, ALKBH5 decreased m6A near splice sites and modulated splicing of MCT4/SLC16A3 mRNA, which regulated lactate accumulation and infiltered immune cell in tumor microenvironment 81.